Pfizer’s $10 Billion Share Buyback Program Doesn’t Increase Stock Prices for the Company

1

Many have viewed Pfizer’s $10 Billion Share Buyback Program as a means to get the PFE stock prices back on track.

Pfizer said it had approved a 36 cents per share dividend, a 6% increase from the same period last year which will be paid on March 1 and authorized a new, $10 billion share repurchase plan, adding to an existing program of around $4.9 billion, which will be phased in over an unspecified period of time. The first quarter dividend is Pfizer’s 321st consecutive shareholder payout by the New York based pharmaceutical group.

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here